CompoAtlas

OESTRAGEN no 2

Natural health product licensed in Canada

Other names
Oesculine2, Oestracol 2, Oestralin2, Oestrocol 2
Licence holder
Mondial Homeo Inc.
NPN or DIN-HM
80084292
Status
Active licence
Licence date
6 April 2018
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Folliculinum

Source : Oestrone de l'ovaire, placenta, testicule, corticosurrénale des mammifères

7 CHNot calculated
Sepia

Source : Jus noir d'encre séché

30 KNot calculated
Cobaltum nitricum

Source : Nitrate cobalteux

6 DHNot calculated
Niccolum sulphuricum

Source : Sulfate de nickel

30 KNot calculated
Pulsatilla

Source : Plante entière

30 CHNot calculated

Non-medicinal ingredients

Eau distillée, Alcool 20%

PopulationAgeQuantity per servingFrequency
AdultesNot specified4 Vaporisateurminimum: 1 Tous les jours ; maximum: 6 Tous les jours

Uses authorised in Canada

Remède homéopathique conseillé pour les symptômes associés aux troubles féminins, des menstruations, de la pré ménopause, ménopause ou post ménopause: entre autres, bouffées de chaleur et céphalées congestives, sècheresse vaginale, perte de libido ou peur de la perdre, humeur maussade.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80084292

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line